| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-12 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-12 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-11 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.3 | 6e-11 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-10 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-10 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.27 | 1e-09 |